Published in Medical Letter on the CDC and FDA, March 26th, 2006
Revenue from research funding in the fourth quarter of 2005 declined $0.3 million to $0.2 million, versus $0.5 million for the fourth quarter of 2004 as a result of lower U.S. National Institutes of Health (NIH) grant funding in 2005 and completion of work performed under other NIH grants in the second quarter of 2005.
Research and development expenses in the fourth quarter of 2005 increased to $7.0...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA